94 related articles for article (PubMed ID: 20551952)
1. Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours.
Funke K; Einsfelder U; Hansen A; Arévalo L; Schneider S; Nettersheim D; Stein V; Schorle H
Br J Cancer; 2023 Jun; 128(12):2270-2282. PubMed ID: 37024667
[TBL] [Abstract][Full Text] [Related]
2. In-ovo echocardiography for application in cardiovascular research.
Hegemann N; Bintig W; Perret PL; Rees J; Viperino A; Eickholt B; Kuebler WM; Höpfner M; Nitzsche B; Grune J
Basic Res Cardiol; 2023 May; 118(1):19. PubMed ID: 37193927
[TBL] [Abstract][Full Text] [Related]
3. Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer.
Bär SI; Dittmer A; Nitzsche B; Ter-Avetisyan G; Fähling M; Klefenz A; Kaps L; Biersack B; Schobert R; Höpfner M
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35485292
[TBL] [Abstract][Full Text] [Related]
4. Co-Culturing of Endothelial and Cancer Cells in a Nanofibrous Scaffold-Based Two-Layer System.
Oh YS; Choi MH; Shin JI; Maza PAMA; Kwak JY
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531897
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
Schmidtova S; Kalavska K; Kucerova L
Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
[TBL] [Abstract][Full Text] [Related]
6. Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors.
Jennewein L; Bartsch G; Gust K; Kvasnicka HM; Haferkamp A; Blaheta R; Mittelbronn M; Harter PN; Mani J
Oncol Lett; 2018 Jun; 15(6):9852-9860. PubMed ID: 29928359
[TBL] [Abstract][Full Text] [Related]
7. Emerging Therapeutic Targets for Male Germ Cell Tumors.
Fankhauser CD; Honecker F; Beyer J; Bode PK
Curr Oncol Rep; 2015 Dec; 17(12):54. PubMed ID: 26449842
[TBL] [Abstract][Full Text] [Related]
8. Combretastatin A-4 derived imidazoles show cytotoxic, antivascular, and antimetastatic effects based on cytoskeletal reorganisation.
Mahal K; Biersack B; Caysa H; Schobert R; Mueller T
Invest New Drugs; 2015 Jun; 33(3):541-54. PubMed ID: 25678082
[TBL] [Abstract][Full Text] [Related]
9. Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors.
Juliachs M; Vidal A; Del Muro XG; Piulats JM; Condom E; Casanovas O; Graupera M; Germà JR; Villanueva A; Viñals F
BMC Cancer; 2013 Aug; 13():382. PubMed ID: 23937707
[TBL] [Abstract][Full Text] [Related]
10. Effect of quinolinyl acrylate derivatives on prostate cancer in vitro and in vivo.
Rodrigues JR; Charris J; Ferrer R; Gamboa N; Angel J; Nitzsche B; Hoepfner M; Lein M; Jung K; Abramjuk C
Invest New Drugs; 2012 Aug; 30(4):1426-33. PubMed ID: 21748298
[TBL] [Abstract][Full Text] [Related]
11. Animacroxam, a Novel Dual-Mode Compound Targeting Histone Deacetylases and Cytoskeletal Integrity of Testicular Germ Cell Cancer Cells.
Steinemann G; Dittmer A; Kuzyniak W; Hoffmann B; Schrader M; Schobert R; Biersack B; Nitzsche B; Höpfner M
Mol Cancer Ther; 2017 Nov; 16(11):2364-2374. PubMed ID: 28838999
[TBL] [Abstract][Full Text] [Related]
12. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets for the treatment of testicular germ cell tumors.
Chieffi P
Mini Rev Med Chem; 2007 Jul; 7(7):755-9. PubMed ID: 17627586
[TBL] [Abstract][Full Text] [Related]
14. [Molecular Pathogenesis of Testicular Germ Cell Tumors].
Bakardjieva-Mihaylova V; Škvárová Kramarzová K; Slámová M; Büchler T; Boublíková L
Klin Onkol; 2017; 30(6):412-419. PubMed ID: 29271211
[TBL] [Abstract][Full Text] [Related]
15. Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.
Nitzsche B; Gloesenkamp C; Schrader M; Ocker M; Preissner R; Lein M; Zakrzewicz A; Hoffmann B; Höpfner M
Br J Cancer; 2010 Jun; 103(1):18-28. PubMed ID: 20551952
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
